dolutegravir

Pharma

Colombia to seek compulsory license on ViiV's dolutegravir

After sparring with GSK’s ViiV Healthcare over the price of its HIV medication dolutegravir, Colombia appears to be taking matters into its own hands.

Fraiser Kansteiner Oct 4, 2023 3:00pm

Gilead, GlaxoSmithKline ink $1.25B patent deal

Feb 1, 2022 4:36pm